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Abstract
We review the case of a young man who developed a constellation of symptoms and signs—bizarre behavior, seizures, abnormal
movements, and autonomic instability—that evaded diagnosis at the time of presentation. We use this case to explore the way
medical knowledge changes over time. Despite the dramatic advances in our understanding of neurological diseases in recent
decades, physicians tend to approach diseases and diagnoses as if they were immutable. Our case reinforces how the diagnosis
and treatment of disease are determined by an ever-changing historical context driven by the rapid expansion of medical
knowledge. We discuss the implications of this realization and present strategies for navigating the boundaries of knowledge, both
in practice and in principle.
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Ignorance was just as dynamic as knowledge, and it grew in the
same proportion. Still, each generation of physicians imagined
that ignorance was the special provenance of their elders.
Abraham Verghese, Cutting for Stone

Introduction
Physicians tend to define diseases with straightforward,
declarative statements like ‘‘Multiple sclerosis is a recurrent
demyelinating disease of the white matter of the CNS, which
usually becomes progressive.’’1(p3) These pronouncements
imply that our knowledge is stable and accurate: that multiple sclerosis is a particular thing and has always been so. If
physicians in past eras thought of diseases differently, they
did so due to their own ignorance. Yet, a long-range view of
medical practice suggests just how much our thinking
changes across time.2 The way a physician names and understands diseases reflects the knowledge and values of that
physician’s era and place. That knowledge and those values
evolve over time; with them, so too do our diagnoses. We
present a brief case that provides an opportunity to explore
the way that physicians understand and interpret the world
and that illustrates how the diagnostic process is shaped by
our place in history.

A Case
A 19-year-old right-handed Canadian-born Chinese male
complained of new frontal headache, odynophagia, and pyrexia. He had previously enjoyed excellent health, with no
past medical or psychiatric issues and no history of substance
abuse. One week later, he became physically aggressive
resulting in his dismissal from work. Over the ensuing
3 weeks, he developed progressive lethargy with periods of
reduced responsiveness. He was admitted to a psychiatric
team for evaluation and management of ‘‘bizarre behavior.’’
Four days later, he experienced a right-sided focal seizure
and was transferred to our tertiary care hospital for neurological assessment.
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Upon arrival, he was diaphoretic, febrile (38.0 C), hypertensive (150/63 mm Hg), and tachycardic (110-120 bpm). His
level of consciousness fluctuated with decreased verbal output. Examination of the cranial nerves and motor systems was
normal. Involuntary repetitive chewing movements of the tongue and lips were observed. Extensive blood and spinal fluid
tests, including all infectious and autoimmune panels, were
normal. Routine awake electroencephalogram demonstrated
only left temporal slowing (3-5 Hz). A brain magnetic
resonance imaging demonstrated scattered nonenhancing
T2/Fluid Attenuated Inversion Recovery (FLAIR) hyperintense lesions within the left corona radiata.
Within days of transfer, he developed autonomic instability
with persistent tachycardia and episodes of hypotension,
necessitating transfer to the intensive care unit. His level of
consciousness continued to fluctuate and he had seizure-like
paroxysms resistant to multiple anticonvulsant medications.
Empiric treatment with pulse methylprednisolone was administered and followed with a prednisone taper. Over the course
of 4 weeks, his autonomic instability stabilized and the level
of consciousness improved. He remained disoriented to place
and time but was able to participate in physiotherapy and was
eventually discharged to inpatient rehabilitation.

Case Analysis
Many readers will recognize features that are familiar for the
diagnosis of anti-N-methyl-D-aspartate receptor (NMDAR)
encephalitis: a limbic encephalitis with rapidly progressive
encephalopathy, seizure-like episodes, orofacial dyskinesias,
and autonomic instability in association with IgG-type autoantibodies against the GluN1 subunit of central nervous system (CNS) NMDARs.3-5 However, our patient was never
tested for autoantibodies against NMDAR. In fact, the diagnosis was never considered because NMDAR encephalitis did
not exist at that time.
Our patient was assessed and managed during the summer
of 2006—6 months before the first series of 12 women was
published3 and 18 months before the first case in a man was
documented.6 While we cannot be certain that our patient
would be diagnosed with NMDAR encephalitis today, we
believe that his case emphasizes the important impact that
historical context exerts on the diagnostic process and on the
conceptualization of disease.
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disease is essential to its nature, modern scholarship has convincingly argued that biology alone is insufficient to understand disease.8
Diseases are manifested by patients and diagnosed by doctors using a process that is influenced by historical and geographical context. Physicians from different eras looking at the
same patient may understand the patient’s symptoms differently. Epilepsy serves as a classical example of this phenomenon, with seizures variably interpreted as a mark of divine
intervention, demonic possession, familial neuroses or genetic
predisposition.9 This variability reflects our tendency to interpret diseases in a manner that integrates the knowledge and
values of the society in which we live.10 Therefore, diseases
are better understood as social constructs rather than natural
kinds. Put simply, diseases are ideas, not things.
As ideas, diseases build upon earlier foundational ideas. In
1934, Polish physician Ludwik Fleck wrote a landmark history of syphilis, demonstrating how that disease had been
understood differently throughout history.11 For Fleck, the
understanding of any disease in a given era is built upon
acceptance of certain ‘‘scientific facts’’ or unquestioned
truths. In one’s historical moment, it is impossible to separate
the concept of a disease from the foundational ‘‘facts’’ upon
which it is based. Similarly, our contemporary understanding
of NMDAR encephalitis is dependent upon foundational concepts like autoimmunity, neuronal receptors, neuroanatomical
localization, and electrophysiology. Without these concepts, it
would be impossible to conceive of ‘‘NMDAR encephalitis’’
as we do today, or to attribute a seemingly disparate group of
symptoms and signs to antibody-mediated dysfunction of
CNS receptors.
This reality highlights one of the flaws with historical studies
that attempt to levy retrospective diagnoses.12 While it is popular to diagnose historical figures with modern diseases,13-15
doing so requires applying diagnoses (and hence terminologies and concepts) from one era to patient descriptions
encoded in another. Retrospective diagnosis therefore tells
us little about how patients in those eras experienced their
illness: our concepts would have no meaning for them, just
as theirs have little meaning for us. Moreover, retrospective
diagnosis does not promote a better understanding of disease
in our time, in that it contributes to the faulty notion that
diseases are natural kinds, and that physicians in past eras
were ever so ignorant about the truths of disease that are now
accepted as ‘‘fact.’’

The Historical Understanding of Disease and Diagnosis
Physicians tend to think about diseases as if they possess
inalienable properties that are stable across time and space.
In this way, we tend to imbue diseases with the properties of
natural kinds.7 A natural kind is a thing that exists in nature
and is beyond human influence; the classic example is gold
whose properties (density, boiling point, etc.) are determined
by its unalterable atomic structure and are therefore constant
across time and space. While the biological element of a

Evolution of NMDAR Encephalitis
Recognition of the historical dependence of our diagnostic
constructs does not invalidate the notion that science progresses. On the contrary, our increasingly sophisticated understanding of NMDAR encephalitis illustrates how rapidly our
conceptualization of a disease can advance. The serendipitous
description of 4 young women with ‘‘paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian
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we learn to appreciate the limits of both our diagnostic expertise and of the efficacy of our treatments.

Conclusions

Figure 1. Bibliometric analysis summarizing the number of academic
publications concerning NMDAR encephalitis from diagnostic
inception to 2015. Articles featuring NMDAR encephalitis were
identified through a Web of Science search using the key word
phrase ‘‘NMDA receptor encephalitis.’’ Articles were further
screened to select English-language manuscripts focusing on the
diagnosis, pathophysiology, or management of NMDAR encephalitis.
Summary totals include original investigations, case reports, review
articles, and letters to the editors divided by the year of publication.
NMDAR indicates N-methyl-D-aspartate receptor.

teratoma,’’16 by a single group in 2005, facilitated the isolation of the etiologic agent (ie, NMDAR autoantibodies) in
2007.3 The description of a causal autoantibody provided not
only a novel understanding of disease pathogenesis but also a
name for this ‘‘new’’ disease, and a scaffold upon which to
integrate the knowledge of NMDAR encephalitis.
To date, well-over 1000 cases of NMDAR encephalitis
have been detailed within an expanding medical literature
comprising over 400 manuscripts (Figure 1). These publications have greatly broadened the clinical experience with
NMDAR encephalitis, yielding an increasingly refined picture
of common symptoms (eg, acute psychiatric symptoms, memory deficits), signs (eg, seizures, decreased level of consciousness, movement disorders,17,18 central hypoventilation), and
disease-associated characteristics (eg, ovarian teratoma,5,19
changes on electroencephalogram,20 neuroimaging findings,21
immunoglobulin composition22). At the same time, increasing
experience with the diagnosis has heralded a marked expansion in the disease spectrum.23 Whereas NMDAR encephalitis
was initially thought to affect only women of childbearing age
with an associated ovarian teratoma,3,16 the disease is now
recognized in males (accounting for approximately 20% of
cases)4,6,24 and all age-groups (from <1- to 84-year-olds25,26).
Predominantly behavioral presentations with minimal neurological sequelae are increasingly recognized.27 Just as we
would now look back at the initial 2005 reports as incomplete
if not outright inaccurate, future physicians will likely consider our present day conceptualizations of NMDAR encephalitis naive. This realization should foster humility within us as

We present a young man with a cluster of symptoms and signs
that were unique and perplexing at the time of presentation. In
the contemporary context, our patient would have been investigated for, and likely diagnosed with, NMDAR encephalitis.
As the diagnostic concept of NMDAR encephalitis did not yet
exist, no such diagnosis was made in our patient, exemplifying
how diagnostic concepts are dependent upon a foundation
anchored in time and place. The way we understand and diagnose disease does, and will continue to, change.
Our analysis suggests 3 relevant lessons. First, case reports
and case series remain essential to the advancement of modern
medical science. The characterization of NMDAR encephalitis was catalyzed by the publication of a small case series. Yet,
the culture of medicine has devalued case reports for producing ‘‘biased’’ evidence.28 However, a historical perspective on
medical knowledge reminds us that all knowledge—even that
generated by ‘‘objective’’ experiments like clinical trials—are
biased, because all knowledge arises within a historical context. Detailed case reports are a highly impactful way for
physicians and scientists to explore unexpected or unexplained phenomena and to probe the boundaries of our knowledge. Case reports also offer the best opportunity to
communicate the story of a patient suffering from an illness,
rather than the antiseptic list of symptoms and signs that typify
well-powered evidence-based studies. It is this story that
appeals to physicians across the world and endures the passage
of time; likewise, it is this story that we should encourage
trainees and seasoned clinicians to tell. Therefore, we encourage journals to publish case reports, and academic institutions
to value them on par with randomized trials.
Second, physicians should be willing to accept that diagnoses and concepts will change. In his influential book, The
Structure of Scientific Revolutions, historian and physicist
Thomas Kuhn proposed that progress in science occurs
through ‘‘revolution,’’ when new ideas overthrow accepted
‘‘facts’’ by better explaining observations or predicting
results.29 In medicine, we might add that revolution occurs
when new concepts reframe how we think about diseases and
lead to better outcomes for patients. However, physicians are
notoriously resistant to changes in their concepts and practices. We suggest that increased exposure to the history of
medicine—from medical school to continuing medical education—provides an opportunity for physicians to assess the
origins of our ideas and to reassess the foundations upon
which our modern understanding of disease are constructed.
Finally, recognition of the humble beginnings and tenuous
boundaries that circumscribe our knowledge should lead physicians away from the need for certainty and toward a renewed
focus on the patient experience. Modern guidelines and treatment algorithms will inevitably be modified and replaced, but
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caring for individual patients will remain central to the practice of medicine. When our available diagnostic concepts fail
to encapsulate the patient experience, we should be willing to
reconsider, reassign, or redefine frameworks; to incorporate
new information whenever possible; and to confront emergent
questions. We become better doctors when we adapt this process to provide the best care for today’s patients. We become
the best doctors when we use the lessons from yesterday to
improve diagnosis today and treatment tomorrow.
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